WM
73
2
PNR
66
3
MRK
32
2
MCO
73
2
HES
56
3
ORLY
65
4
FSLR
47
3
HRB
55
3
EXR
46
2
EIX
67
5
AXP
73
3
O
50
2
BRK.B
49
2
KMX
58
4
RSG
70
2
ORCL
65
2
DD
42
2
LEN
61
2
EA
31
-3
CME
48
2
WM
73
2
PNR
66
3
MRK
32
2
MCO
73
2
HES
56
3
ORLY
65
4
FSLR
47
3
HRB
55
3
EXR
46
2
EIX
67
5
AXP
73
3
O
50
2
BRK.B
49
2
KMX
58
4
RSG
70
2
ORCL
65
2
DD
42
2
LEN
61
2
EA
31
-3
CME
48
2
Financhill
Back

ProShares Ultra Dow30 Vs. Kymera Therapeutics Industry Stock Comparison

Buy
81

DDM
ProShares Ultra Dow30

Last Price:
98.78
Seasonality Move:
8.96%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
48.99
Seasonality Move:
65.72%
Buy
81
ProShares Ultra Dow30 (DDM) is a Buy

Is ProShares Ultra Dow30 a Buy, Sell or Hold?

  • The current ProShares Ultra Dow30 [DDM] share price is $98.78. The Score for DDM is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
  • DDM is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DDM Stock Price Chart

What is ProShares Ultra Dow30's stock price today?

  • The ProShares Ultra Dow30 share price today is $98.78
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DDM is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

DDM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.72 Buy
Relative Strength Index (14 RSI): 65.01 Buy
Chaikin Money Flow: 116185 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (93.06 - 96.92) Buy
Bollinger Bands (100): (82.95 - 93.21) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

DDM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 96.71 Buy
20-day SMA: 95.68 Buy
50-day SMA: 91.74 Buy
200-day SMA: 85.17 Buy
8-day EMA: 97.16 Buy
20-day EMA: 95.52 Buy
50-day EMA: 92.56 Buy
200-day EMA: 84.89 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

ProShares Ultra Dow30 Earnings Growth & DDM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

ProShares Ultra Dow30 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):